Experimental NIH malaria monoclonal antibody protective in Malian children
Experimental NIH malaria monoclonal antibody protective in Malian children Mid-stage trial shows treatment prevents infection,…
Experimental NIH malaria monoclonal antibody protective in Malian children Mid-stage trial shows treatment prevents infection,…
Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard…
NIH study shows chronic wasting disease unlikely to move from animals to people Study of…
High H5N1 influenza levels found in mice given raw milk from infected dairy cows Mice…
Introducing peanut in infancy prevents peanut allergy into adolescence NIH study finds protection lasts no…
Novel vaccine concept generates immune responses that could produce multiple types of HIV broadly neutralizing…
Existing drug shows promise as treatment for rare genetic disorder NIH researchers find new pathways…
U.S. clinical trials begin for twice-yearly HIV prevention injection Studies will focus on priority populations…
NIH releases H5N1 influenza research agenda Understanding virus biology, advancing detection, treatment and prevention strategies…
Infectious H5N1 influenza virus in raw milk rapidly declines with heat treatment The amount of…